Cholesterol crystal dissolution rate of serum is associated with iliofemoral calcification and predicts outcomes in patients undergoing TAVR

Back

ESC Professional Premium Access

Cholesterol crystal dissolution rate of serum is associated with iliofemoral calcification and predicts outcomes in patients undergoing TAVR

Session: Advances and remaining challenges in percutaneous valve intervention

Topic: Intervention

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Baravan Al-Kassou

University hospital Bonn, Bonn (Germany)

2 presentations

2 followers

7 more presentations in this session

Early outcomes of the PASCAL P10 and the MitraClip XT transcatheter mitral leaflet approximation devices - A propensity score matched multicentre comparison

Speaker: Doctor P. von Stein (Cologne, DE)

Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation - Results from the SOLVE-TAVI trial

Speaker: Doctor H. Feistritzer (Leipzig, DE)

Up to 6-year performance and clinical outcomes of balloon expandable transcatheter aortic valve according to the implantation strategy: insight from the DIRECTAVI trial

Speaker: Professor F. Leclercq (Montpellier, FR)

Access

Abstract

Slides

Clinical and neurocognitive outcomes in patients with supra-arch vascular disease following transcatheter aortic valve replacement

Speaker: Doctor T. Ko (Taipei, TW)

Influence of device generations on alternations of mitral annulus after transcatheter edge-to-edge repair: a real-time three-dimensional transesophageal echocardiography study

Speaker: Ms M. Ohmori (Tokyo, JP)

Access the full session

Advances and remaining challenges in percutaneous valve intervention

Speakers: Doctor B. Al-Kassou, Doctor P. von Stein, Doctor H. Feistritzer, Professor F. Leclercq, Doctor T. Ko...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Cholesterol crystal dissolution rate of serum is associated with iliofemoral calcification and predicts outcomes in patients undergoing TAVR

About the speaker

Doctor Baravan Al-Kassou

7 more presentations in this session

Early outcomes of the PASCAL P10 and the MitraClip XT transcatheter mitral leaflet approximation devices - A propensity score matched multicentre comparison

Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation - Results from the SOLVE-TAVI trial

Up to 6-year performance and clinical outcomes of balloon expandable transcatheter aortic valve according to the implantation strategy: insight from the DIRECTAVI trial

Clinical and neurocognitive outcomes in patients with supra-arch vascular disease following transcatheter aortic valve replacement

Influence of device generations on alternations of mitral annulus after transcatheter edge-to-edge repair: a real-time three-dimensional transesophageal echocardiography study

Access the full session

Advances and remaining challenges in percutaneous valve intervention

About the event

ESC Congress 2023

ESC 365 is supported by